| Ytd | -35.46% | |
| 1y | -60.34% |
| Open | 0.97 | Prev Close | 0.89 | Low | 0.85 | High | 0.97 | Mkt Cap | 1.69M |
| Vol | 19.78K | Avg Vol | 65.75K | EPS | -2.27 | P/E | -0.41 | Forward P/E | -0.41 |
| Beta | 0.92 | Short Ratio | 0.18 | Inst. Own | 4.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.22 | 200-d Avg | 1.43 | 1yr Est | 16.75 |
Bone Biologics (NASDAQ: BBLG - Get Free Report) will likely be issuing its results before the market
BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW)
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's
iOThree Ltd (IOTR) rose in premarket trading after strong fiscal 2026 results. Gainers include EDBL,
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds up
href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in
Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened bal
Milestone advances manufacturing readiness and supports long-term commercialization strategy Milesto
Bone Biologics Corp. (NASDAQ: BBLG - Get Free Report)'s share price fell 0.5% during trading on Wedn
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
Bone Biologics Corporation BBLG stock is trading higher on Friday, with a session volume of 17.22 mi
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #Bonebiologics--Bone Biologics files U.S. patent applic
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthob
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a
On Monday, 369 companies set new 52-week lows.
Wednesday's session saw 150 companies set new 52-week lows.
Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after p
On Monday, 61 companies hit new 52-week lows.
On Monday, 413 companies reached new 52-week lows.
On Friday, 404 stocks made new 52-week lows.
During Monday's session, 402 companies made new 52-week lows.
On Friday, 137 stocks made new 52-week lows.
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Th
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday
Tuesday's session saw 729 companies set new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The compan
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-m
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
Following the market opening Monday, the Dow traded down 0.95% to 35,888.97 while the NASDAQ fell 1.
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched